ARA-290 is variant of erythropoietin which has been shown to decrease inflammatory pathways through paracrine signalling and the innate repair receptors. Research has shown ARA-290 to help reduce HbA1c, improve cholesterol, modulate neuropathic pain and stimulate wound repair.
New
ARA-290 16mg
$95.00
ARA-290 is variant of erythropoietin which has been shown to decrease inflammatory pathways through paracrine signalling and the innate repair receptors. Research has shown ARA-290 to help reduce HbA1c, improve cholesterol, modulate neuropathic pain and stimulate wound repair.
Description
Shipping & Delivery
Related products
B7-33 6mg
B7-33 exibits potent anti-fibrotic effects. It is under active research and investigation as a means of reducing fibrosis in acute and chronic diseases like heart failure, lung inflammation, kidney and more. In animal studies, B7-33 has reduced fibrosis by roughly 50%, leading to prolonged survival following injury and offering the first new means of treating heart failure in 20 years. It has been shown to reduce excessive scar formation following cardiac injury. It has also shown promise in the treatment of certain vascular disorders as well as preeclampsia of pregnancy.
Gut Inflammation (60 Capsules) (Stable BPC-157 Arginate, KPV, Larazotide) FREE Shipping
BPC-157 Arginate Salt is very stable in human gastric juice and boosts the oral bioavailability from less than 3% to greater than 90%. BPC 157 arginate salt is also more stable in varied temperature environments and can resist the effects of UV light. Studies show that just 5% of BPC 157 arginate is degraded after 5 hours in gastric acid as compared to 98% of the acetate salt with oral administration. The enhanced oral bioavailability of the arginate salt makes it the preferred choice in BPC 157 oral research.
Longevity, Performance & Obesity Research (60 Capsules)
5-amino-1MQ is a small molecule that blocks the activity of the enzyme called nicotinamide N-methyltransferase (NNMT). By blocking NNMT, 5-amino-1MQ stimulates an increase in NAD+, a cofactor that is central to cellular metabolism, thereby increasing metabolic rate and activating a gene called sirtuin-1 (SIRT1). SIRT1 is also known as the "longevity gene" because of its role in reducing the risk of diabetes, obesity, metabolic syndrome, atherosclerosis and other forms of cardiovascular disease, kidney disease, liver disease, neurodegeneration, and cancer.
MK-677 (Ibutamoren) 12.5mg (60 Capsules)
MK-677, is a orally bio-active, selective agonist of the ghrelin receptor. Research shows that MK-677 increases the natural secretion of growth hormone (GH) and insulin-like growth factor 1 (IGF-1), but does not affect cortisol levels. It is being researched as a possible treatment for GH deficiency, muscle and bone wasting, appetite stimulation and Alzheimer's disease. MK-677 research in mice, appeared to prevent the onset of AD, even in genetically predisposed mice, as long as it was started before significant amyloid beta accumulation. MK-677 research has also shown exceptionally promising benefits in improving sleep quality.
OS-01 (100mg x 30 Capsules)
OS-01 is an AMP-activated protein kinase (AMPK) activator that modulates cellular energy homeostasis and metabolic function. AMPK, a central regulator of energy balance, is activated in response to low intracellular ATP levels, enhancing glucose uptake, fatty acid oxidation, and mitochondrial biogenesis. OS-01 stimulates AMPK phosphorylation, leading to increased ATP production, improved insulin sensitivity, and enhanced autophagic flux, thereby promoting cellular repair and longevity. This compound has been shown to mitigate oxidative stress by downregulating reactive oxygen species (ROS) and inflammatory cytokines, reducing cellular damage and aging-related dysfunction. Additionally, OS-01 enhances endurance by optimizing energy substrate utilization and preserving glycogen stores during exercise. It plays a protective role in renal and cardiovascular systems by attenuating fibrosis, reducing endothelial dysfunction, and improving mitochondrial efficiency. Preclinical studies suggest its potential in managing metabolic disorders, including type 2 diabetes, obesity, and cardiovascular diseases, by improving glucose homeostasis and reducing insulin resistance. Furthermore, OS-01’s activation of autophagy contributes to neuroprotection, reducing age-related neurodegeneration. Its multifaceted mechanism positions it as a promising candidate for therapeutic intervention in metabolic and age-related diseases.
SLU-PP-332
SLU-PP-332 (250mcg x 60 Capsules = 15,000mcg) SLU-PP-332 (1000mcg x 30 Capsules = 30,000mcg) SLU-PP-332 is an experimental compound designed to mimic the metabolic effects of exercise by activating estrogen-related receptors (ERRs), particularly ERRα, ERRβ, and ERRγ. This activation leads to increased energy expenditure, enhanced fatty acid oxidation, and improved mitochondrial function.
Reviews
There are no reviews yet.